Are you at risk for C.diff? • Do you have an upcoming SURGERY, requiring you to be hospitalized for several days? • Have you been HOSPITALIZED TWICE in the last year and received antibiotics? • Are you 50 years of age or older?
-
- STATUS
- Recruiting
-
- sponsor
- Sanofi-Pasteur
Summary
Are you at risk for C.diff? • Do you have an upcoming SURGERY, requiring you to be hospitalized for several days? • Have you been HOSPITALIZED TWICE in the last year and received antibiotics? • Are you 50 years of age or older?
Description
Individuals most at-risk for C. diff have a generally weakened condition, have received antibiotics, and are likely to have been hospitalized or residing in Long Term Care Facilities. Clostridium difficile (C-diff) is a potentially deadly, spore-forming bacterium emerging as the leading cause of life-threatening, healthcare-associated infections worldwide.
C.diff toxins cause gastrointestinal disease that can lead to death. Symptoms range from mild diarrhea to life-threatening colitis and often include dehydration, abdominal pain and spasms.
350,000 American people are hospitalized every year due to this disease, 77% of cases being in people above 50 years old. In hospital wards, C.diff contamination has been found on 49% of sites in rooms occupied by previous patients with C.diff even after cleaning measures.
Other Details:
You may be eligible to help us develop a vaccine to protect at risk individuals like yourself from a serious healthcare associated infection; Clostridium difficile.
Details
| Condition | Clostridium Difficile-Associated Diarrhea |
|---|---|
| Clinical Study Identifier | TX141065 |
| Sponsor | Sanofi-Pasteur |
| Last Modified on | 23 November 2020 |
How to participate?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer